S-Alpha Therapeutics

Healthcare ITSeries CSeoul, South Koreasalphadtx.com

Latest round

Series C

Last raised

Oct 2025

Total raised

$23M

Investors

13

About S-Alpha Therapeutics

Founded in 2019 and based in Seoul, South Korea, S-ALPHA THERAPEUTICS. Inc. operates as a developer of digital therapeutics and health applications that help patients with chronic diseases such as diabetes and mental illnesses. The company was certificated as Company Affiliated Research Institute by Korea Institute for Advancement of Technology. The pipelines manufactured by the company are SAT-001, SAT-002, SAT-006, SAT-008 and SAT-003. These pipelines can be used in ophthalmology, neurology, oncology, gastroenterology and public crisis. The company has cooperated with LegoChemBio, Stonebridge and other enterprises.

Who invested in S-Alpha Therapeutics

13 investors across 4 rounds

See all investors in S-Alpha Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Oct 30, 2025

    Amount

    $3.4M

    Investors

    Locked

  2. Series B

    Feb 28, 2023

    Amount

    $8.5M

    Investors

    Locked

  3. Series A

    Aug 4, 2021

    Amount

    $8.7M

    Investors

    Locked

  4. Seed

    Nov 20, 2020

    Amount

    $2.8M

    Investors

    Locked

Questions about S-Alpha Therapeutics

Who invested in S-Alpha Therapeutics?

S-Alpha Therapeutics has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has S-Alpha Therapeutics raised?

S-Alpha Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did S-Alpha Therapeutics last raise money?

S-Alpha Therapeutics's most recent round on record is a Series C, in Oct 2025.

What does S-Alpha Therapeutics do?

Founded in 2019 and based in Seoul, South Korea, S-ALPHA THERAPEUTICS.

Where is S-Alpha Therapeutics headquartered?

S-Alpha Therapeutics is headquartered in Seoul, South Korea.

Which VCs invest in companies like S-Alpha Therapeutics?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare it companies at S-Alpha Therapeutics's stage. Their profiles are linked below.

Raising like S-Alpha Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.